妙佑医疗国际的方法

一名妙佑医疗国际的医生向需要接受前列腺手术的患者解释前列腺切除术方案。 问题的答案

在妙佑医疗国际,医生会仔细倾听您的问题并解释您的前列腺切除术方案。

全面的个性化方法

整个手术过程高度私密化。在妙佑医疗国际,医生会倾听您的担忧和相关问题。他们将与您配合,共同讨论前列腺切除术的所有方案和方法。医生会回答您的问题,并根据您的独特需求制定护理计划。妙佑医疗国际在前列腺切除术方面具备丰富经验和技术能力,为患者营造安心可靠、以人为本的环境。妙佑医疗国际将尖端科学技术、人性化护理和显著疗效相结合,吸引了来自世界各地的患者前来接受前列腺癌护理。

妙佑医疗国际的医生合作开展前列腺切除术护理工作。 团队合作治疗

妙佑医疗国际的外科医生与同事讨论治疗方案。

经验、专业技能和团队协作

妙佑医疗国际泌尿外科医生和医护团队在前列腺切除术的各个层面全面合作。他们凭借丰富的治疗经验和卓越的专业技能,造福每一位患者。无缝衔接的团队协作使护理更加协调,治疗进程更快,也使接受护理的患者更加满意。

妙佑医疗国际的泌尿科医生已经进行了数十年的根治性前列腺切除术。每年有超过 1500 人选择在妙佑医疗国际进行此类医疗程序。研究表明,手术结果与外科医生实施手术次数直接相关。

妙佑医疗国际的外科医生正在实施前列腺切除术 经验丰富的外科医生

妙佑医疗国际的外科医生在各种形式的前列腺切除术方面有着丰富的经验,每年都会进行大量的手术。

先进的技术和治疗方案

妙佑医疗国际的外科医生是各种根治性前列腺切除术(包括机器人辅助前列腺切除术)的专家。妙佑医疗国际的外科医生率先采用机器人辅助前列腺切除术,并在多年间成功实施并改善这项手术。

一名外科医生坐在远程控制台,进行机器人辅助前列腺切除术。 机器人辅助前列腺切除术

妙佑医疗国际的外科医生坐在远程控制台旁,用机械臂进行机器人辅助前列腺切除术,外科团队在手术台旁提供协助。

与传统的腹腔镜手术相比,在腹腔镜手术中使用连接至机器人的器械有助于外科医生更精准地移动手术工具。

数十年来,妙佑医疗国际的外科医生一直在开展和完善根治性前列腺切除术,包括开放性手术和机器人辅助手术形式。机器人前列腺切除术技术和技巧方面也取得了重大进展。

研究与创新

妙佑医疗国际营造出可推动实践变革创新的研究环境。妙佑医疗国际的研究人员积极参与研究根治性前列腺切除术后的长期预后。几十年来,妙佑医疗国际一直致力于维护接受过前列腺癌手术的患者数据库。通过该数据库,妙佑医疗国际的医生和研究人员可跟踪治疗和预后,从而开发出最有可能为患者带来最佳疗效和生活质量的技术。

专长与排名

妙佑医疗国际的泌尿外科医生和医护团队利用其数十年的经验和专业技能以及研究进展,确保接受前列腺切除术的患者能够实现最佳预后。妙佑医疗国际做过大量手术、临床试验和先进治疗,因此能为接受护理的患者提供最佳护理体验。

经验和专业技能

妙佑医疗国际的泌尿科医生已经进行了数十年的根治性前列腺切除术。实际上,妙佑医疗的外科医生每年平均实施 1500 多例此类手术。研究表明,如果医生做过多例前列腺手术,并在为大量接受过前列腺手术的患者提供护理的医疗中心工作,通常能提供更好的治疗结果。

综合癌症中心

妙佑医疗国际综合癌症中心符合美国国家癌症研究所综合癌症中心的严格标准。这些标准是对癌症预防、诊断和治疗方面的卓越科学成就和多专科诊疗模式的认可。

全美广受认可的专业实力

妙佑医疗国际明尼苏达州罗切斯特院区、妙佑医疗国际佛罗里达州杰克逊维尔院区和妙佑医疗国际亚利桑那州凤凰城/斯科茨代尔院区均在《美国新闻与世界报道》癌症和泌尿学领域“最佳医院”排名中名列前茅。

位置、旅行和住宿

Mayo Clinic 在亚利桑那州的芬尼克斯和斯克茨戴尔、佛罗里达州的杰克逊威尔和明尼苏达州的罗切斯特都有主要校区。Mayo Clinic 健康系统在几个州拥有十几个工作地点。

有关参观 Mayo Clinic 的更多信息,请在下面选择您的位置:

费用与保险

妙佑医疗国际与数百家保险公司合作,是数百万人的网络内医疗服务提供者。

在大多数情况下,妙佑医疗国际不需要医生转诊。某些保险公司要求转诊,或有其他特定医疗要求。所有约诊的优先级都以医疗需求为基础。

详细了解在妙佑医疗国际约诊的信息。

请联系您的保险公司,核实承保范围,并在就医之前获得任何所需的授权。保险公司的客户服务号码通常印在保险卡背面。

Jan. 13, 2026
  1. Khanna A (voice recording). Mayo Clinic; recorded Oct. 2024.
  2. McVary KT. Surgical treatment of benign prostatic hyperplasia (BPH). https://www.uptodate.com/contents/search. Accessed July 28, 2025.
  3. Health Education & Content Services. Your robotic-assisted prostate surgery. Mayo Clinic; 2024.
  4. Surgery for prostate cancer. Prostate Cancer Foundation. https://www.pcf.org/about-prostate-cancer/prostate-cancer-treatment/surgery-prostate-cancer/. Accessed July 28, 2025.
  5. Dmochowski RR, et al., eds. Simple prostatectomy — Open, laparoscopic, and robotic approaches. In: Campbell-Walsh-Wein Urology. 13th ed. Elsevier; 2026. https://www.clinicalkey.com. Accessed July 28, 2025.
  6. Surgery for prostate cancer. American Cancer Society. https://www.cancer.org/cancer/types/prostate-cancer/treating/surgery.html. Accessed July 28, 2025.
  7. Moreira DM, et al. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy. BJU International. 2017; doi:10.1111/bju.13266.
  8. Motterle G, et al. The role of radical prostatectomy and lymph node dissection in clinically node positive patients. Frontiers in Oncology. 2019; doi:10.3389/fonc.2019.01395.
  9. Ami TR. Allscripts EPSi. Mayo Clinic. March 29, 2024.
  10. Costello AJ. Considering the role of radical prostatectomy in 21st century prostate cancer care. Nature Reviews Urology. 2020; doi:10.1038/s41585-020-0287-y.
  11. Agarwal DK, et al. Initial experience with da Vinci single-port robot-assisted radical prostatectomies. European Urology. 2020; doi:10.1016/j.eururo.2019.04.001.
  12. Ashfaq A, et al. Incidence and outcomes of ventral hernia repair after robotic retropubic prostatectomy: A retrospective cohort of 570 consecutive cases. International Journal of Surgery. 2017; doi:10.1016/j.ijsu.2016.12.034.
  13. Moris L, et al. Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection. Frontiers in Surgery. 2016; doi:10.3389/fsurg.2016.00065.
  14. Kaushik D, et al. Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer. International Brazilian Journal of Urology. 2016; doi:10.1590/S1677-5538.IBJU.2016.0290.
  15. Alshalalfa M, et al. Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: Exploratory analysis from 12,076 patients. Oncotarget. 2017; doi:10.18632/oncotarget.15133.
  16. Preparing for surgery: Checklist. American Society of Anesthesiologists. https://www.asahq.org/madeforthismoment/preparing-for-surgery/prep/preparing-for-surgery-checklist/. Accessed July 28, 2025.
  17. Dess RT, et al. Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer. JAMA Oncology. 2020; doi:10.1001/jamaoncol.2020.0109.
  18. Richie JP. Radical prostatectomy for localized prostate cancer. https://www.uptodate.com/contents/search. Accessed July 28, 2025.
  19. He S, et al. Robot-assisted radical resection in prostate cancer comparative assessment with conventional laparoscopic prostatectomy: A retrospective comparative cohort study with single-center experience. Translational Andrology and Urology. 2022: doi: 10.21037/tau-22-739.
  20. Stringfield SB, et al. Experience with 10 years of a robotic surgery program at an academic medical center. Surgical Endoscopy. 2021; doi:10.1007/s00464-021-08478-y.
  21. Salinas CS, et al. Efficacy of robotic-assisted prostatectomy in localized prostate cancer: A systematic review of clinical trials. Advances in Urology. 2013; doi:10.1155/2013/105651.
  22. Kim DK, et al. Comparison of robot-assisted, laparoscopic, and open radical prostatectomy outcomes: A systematic review and network meta-analysis from KSER update series. Medicina. 2025; doi:10.3390/medicina61010061.
  23. Franco A, et al. Single port robot-assisted radical and simple prostatectomy: A systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 2024; doi:10.1038/s41391-024-00787-2.
  24. Transurethral resection of the prostate (TURP). Mayo Clinic. https://www.mayoclinic.org/tests-procedures/turp/about/pac-20384880. Accessed Aug. 1, 2025.
  25. Prostate cancer. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087. Accessed Aug. 1, 2025.
  26. Azad AA, et al. Enzalutamide and prostate-specific antigen levels in metastatic prostate cancer: A secondary analysis of the ARCHES randomized clinical trial. JAMA Network Open. 2025; doi:10.1001/jamanetworkopen.2025.8751.
  27. Primary care management of the post prostate cancer patient. Video. Mayo Clinic; 2021. https://educationmedia.mayo.edu/media/Primary%20Care%20Management%20of%20the%20Post%20Prostate%20Cancer%20Patient/1_sqwb1249. Accessed Sept. 8, 2025.
  28. Spek A, et al. Single-fraction image-guided robotic radiosurgery efficiently controls local prostate cancer recurrence after radical prostatectomy. BJUI Compass. 2020; doi:10.1002/bco2.32.
  29. Turk H, et al. Predictive factors for biochemical recurrence in radical prostatectomy patients. Central European Journal of Urology. 2015; doi:10.5173/ceju.2015.606.
  30. Tugcu V, et al. Robot-assisted radical perineal prostatectomy: First experience of 15 cases. Turkish Journal of Urology. 2017; doi:10.5152/tud.2017.35488.
  31. Sharma NL, et al. Robotic-assisted laparoscopic prostatectomy. British Journal of Cancer. 2009; doi:10.1038/sj.bjc.6605341.
  32. Linder BJ, et al. Effect of surgical care team consistency during urologic procedures on surgical efficiency and perioperative outcomes. Urology. 2023; doi:10.1016/j.urology.2023.02.004.
  33. Steinberg, RL, et al. Magnet-assisted robotic prostatectomy using the da Vinci SP robot: An initial case series. Journal of Endourology. 2019; doi:10.1089/end.2019.0263.

机器人前列腺切除术